The CPRIT announced a Seed Award for early-stage oncology startup companies
On Apr. 30, 2018, the Cancer Prevention and Research Institute of Texas (CPRIT) announced a Seed Award for…
Medigen Vaccines and GC Pharma collaborated to commercialize quadrivalent influenza vaccine in Taiwan
On Apr. 23, 2018, Medigen Vaccine Biologics and GC Pharma entered an exclusive distribution agreement for GCC’s quadrivalent…
NIMH awarded a $12.7 million grant to Emory University for oxytocin research
On Apr. 16, 2018, the National Institute of Mental Health (NIMH) awarded a $12.7 million grant to Emory…
Biotechnology | Diagnostics | Disease | Life Science News | Medicine | NIH | Non-Profit Research | Therapeutics
NIH completed in-depth genomic analysis of 33 cancer types
On Apr. 5, 2018, researchers funded by the National Institutes of Health (NIH) announced they had completed a…
USC scientists launched global effort to find the next diabetes drug
On Mar. 23, 2018, University of Southern California (USC) researchers launched a massive scientific effort to construct a…
UW Med school formed world’s first Health Metrics Sciences department
On Mar. 15, 2018, the University of Washington School of Medicine announced the establishment of the world’s first…
Biotechnology | Diagnostics | Disease | Life Science News | Medicine | Neurology | Non-Profit Research | Therapeutics
Norris Healthcare Center opened for patient care
On Mar. 9, 2018, the Keck Medicine of University of Southern California (USC) significantly expanded its patient care…
Seattle Genetics acquired Cascadian Therapeutics
On Mar. 9, 2018, Seattle Genetics announced it had completed its acquisition of Cascadian Therapeutics for approximately $614…
Partner Therapeutics acquired Sanofi’s Leukine and Lynnwood manufacturing facility
On Mar. 9, 2018, Boston-based cancer company Partner Therapeutics announced that it had acquired the global rights to…
Sanofi acquired Bioverativ for $11.6 billion
On Mar. 8, 2018, Sanofi acquired Waltham, Massachusetts-based Bioverativ for for $11.6 billion. Bioverativ’s extended half-life therapies, Eloctate…
FDA authorized direct-to-consumer test that reports three mutations in the BRCA breast cancer genes
On Mar. 6, 2018, the U.S. Food and Drug Administration authorized 23andMe’s Personal Genome Service Genetic Health Risk…
OHSU Doernbecher was the first in PNW to be ACS-verified as a Level 1 pediatric trauma center
On Feb. 22, 2018, OHSU Doernbecher Children’s Hospital was verified as a Level 1 Pediatric Trauma Center and…
Artificial Intelligence | Biotechnology | Diagnostics | Disease | Genomics | Life Science News | Medicine | Non-Profit Research | Pharmaceutical | Therapeutics | Vaccine
PNNL and OHSU created joint research co-laboratory to advance precision medicine
On Feb. 14, 2018, Pacific Northwest National Laboratory, (PNNL) and Oregon Health & Science University OHSU announced the…
FDA published guidance to industry known as the “red book”
On Jan. 31, 2018, the FDA published the first Red Book, the successor to 1949 “black book,” officially…
Biotechnology | CDC | Life Science News | NIH | Non-Profit Research | Pharmaceutical | Therapeutics | Vaccine
CDC published ACIP recommendations for use of herpes zoster vaccines
On Jan. 26, 2018, the U.S. Centers for Disease Control and Prevention’ (CDC) Immunization Practices Advisory Committee (ACIP)…
Biotechnology | Diagnostics | Life Science News | Medical Device | Medicine | Non-Profit Research | Therapeutics
Cleveland Clinic partnered with Martin Health System for first cardiovascular affiliation in Florida
On Jan. 26, 2018, Cleveland Clinic and Martin Health System announced an affiliation agreement to share best practices…
Celgene acquired Juno Therapeutics for $9 billion
On Jan. 22, 2018, Celgene and Juno Therapeutics announced the signing of a merger agreement in which Celgene…
The University of Michigan Cancer Center was renamed the Rogel Cancer Center
In 2018, the University of Michigan Cancer Center was renamed the Rogel Cancer Center in recognition of a…
Biotechnology | Diagnostics | Disease | Genomics | Life Science News | Medicine | Non-Profit Research | Therapeutics
Native BioData Consortium was founded
In 2018, the Native BioData Consortium was founded as a 501(c)(3) nonprofit research institute led by Indigenous scientists…
Omahan Donated $3 million for prostate cancer research to Buffett Cancer Center
On Dec. 13, 2017, longtime Omaha art teacher and businessman Gerald “Jerry” Pabst donated $3 million through an…
Costco co-founder Jeff Brotman and Dan Baty donated $50 million to create the Brotman Baty Institute for Precision Medicine
On Dec. 6, 2017, Costco Founder Jeffrey and Susan Brotman and Pam and Dan Baty announced a $50…
Ozempic (semaglutide) was approved in the U.S.
On Dec. 5, 2017, Novo Nordisk announced that the U.S. Food and Drug Administration (FDA) had approved Ozempic…
Biotechnology | Disease | FDA | Life Science News | Oncology | Therapeutics
FDA approved first biosimilar for the treatment of certain breast and stomach cancers
On Dec. 1, 2017, the U.S. Food and Drug Administration (FDA) approved Mylan’s Ogivri (trastuzumab-dkst) as a biosimilar…
Scientists Created First Semi-Synthetic Organism that Stored and Retrieved Unnatural Information
On Nov. 29, 2017, scientists at The Scripps Research Institute (TSRI) announced they had designed a bacterium with…
Genentech drug Hemlibra (emicizumab-kxwh) was approved
On Nov. 16, 2017, the the U.S. Food and Drug Administration (FDA) approved the Genentech drug Hemlibra (emicizumab-kxwh)…
Irving Family bequests $700 Million to Columbia and NewYork-Presbyterian for Cancer Research and Care
On Nov. 16, 2017, Columbia University and NewYork-Presbyterian announced that Florence Irving and her late husband, Herbert Irving,…
The Calgary Cancer Centre broke ground
On Nov. 3, 2017, construction started on the Calgary Cancer Centre located at the northeast corner of the…
Biotechnology | Disease | Life Science News | Non-Profit Research | Oncology | Radiology | Therapeutics
Siteman Cancer Center became one of the first cancer centers nationwide to offer newly approved CAR-T cell therapy called Yescarta
On Oct. 18, 2017, the Siteman Cancer Center became one of the first cancer centers nationwide to offer…
Paul G Allen Frontiers Group announced two new Allen Discovery Centers
On Oct. 11, 2017, the Paul G. Allen Frontiers Group announced the creation of two new Allen Discovery…
$13.4 million to build next-gen MRI brain scanner at UC Berkeley
On Oct. 6, 2017, UC Berkeley researchers announced they had developed reimagined fMRI techniques and instruments to boost…